Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Prostate cancer continues to be a major health threat, especially among African American men. The Selenium and Vitamin E Cancer Prevention Trial (SELECT), which opened on July 25, 2001, was planned to study possible agents for the prevention of prostate cancer in a population of 32,400 men in the United States, including Puerto Rico, and Canada. SELECT is a phase III randomized, placebo-controlled trial of selenium (200 microg/day from L-selenomethionine) and/or vitamin E (400 IU/day of all rac alpha-tocopheryl acetate) supplementation for a minimum of 7 years (maximum of 12 years) in non-African American men at least 55 years of age and African American men at least 50 years of age. SELECT is a large, simple trial that conforms as closely as possible with community standards of care. This commentary discusses the design problems the SELECT investigators had to resolve in developing the trial, including the role of prostate cancer screening, the best forms and doses of the study agents, and estimation of the event (prostate cancer) rate of men on the placebo arm.

[1]  E. Rimm,et al.  Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. , 1998, Journal of the National Cancer Institute.

[2]  H. Esterbauer,et al.  Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. , 1991, Journal of lipid research.

[3]  L. Kopelovich,et al.  In vitro evaluation of chemopreventive agents using cultured human prostate epithelial cells. , 2003, Oncology reports.

[4]  J. Judd,et al.  Vitamin E and relationships among tocopherols in human plasma, platelets, lymphocytes, and red blood cells. , 1988, The American journal of clinical nutrition.

[5]  R A Stephenson,et al.  Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. , 2000, Journal of the National Cancer Institute.

[6]  M. Gail,et al.  Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. , 1993, Journal of the National Cancer Institute.

[7]  G. Combs,et al.  Status of selenium in prostate cancer prevention , 2004, British Journal of Cancer.

[8]  P. Scardino,et al.  The prevention of prostate cancer--the dilemma continues. , 2003, The New England journal of medicine.

[9]  W. Willett,et al.  A prospective study of plasma selenium levels and prostate cancer risk. , 2004, Journal of the National Cancer Institute.

[10]  H. Arai,et al.  Molecular mechanisms of vitamin E transport. , 1999, Annual review of nutrition.

[11]  Michael M Lieber,et al.  The influence of finasteride on the development of prostate cancer. , 2003, The New England journal of medicine.

[12]  D. Bostwick,et al.  Does finasteride alter the pathology of the prostate and cancer grading? , 2004, Clinical prostate cancer.

[13]  L. Klotz,et al.  Synergistic effect of vitamin E and selenium in human prostate cancer cell lines , 2004, Prostate Cancer and Prostatic Diseases.

[14]  D. Alberts,et al.  Selenium and colorectal adenoma: results of a pooled analysis. , 2004, Journal of the National Cancer Institute.

[15]  C. Ip,et al.  Lessons from basic research in selenium and cancer prevention. , 1998, The Journal of nutrition.

[16]  R. Brigelius-Flohé,et al.  Vitamin E: function and metabolism , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[18]  E. Bolson,et al.  Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. , 2001, The New England journal of medicine.

[19]  J. Crowley,et al.  Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. , 2004, The New England journal of medicine.

[20]  L. Clark,et al.  Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. , 1998, Cancer letters.

[21]  J. Stanford,et al.  Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[22]  V. Freeman,et al.  Prostatic levels of tocopherols, carotenoids, and retinol in relation to plasma levels and self-reported usual dietary intake. , 2000, American journal of epidemiology.

[23]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[24]  A. Papas.  Antioxidant Status, Diet, Nutrition, and Health , 1998 .

[25]  G. Schrauzer.  Selenomethionine: a review of its nutritional significance, metabolism and toxicity. , 2000, The Journal of nutrition.

[26]  R. Vieth,et al.  Vitamin D insufficiency: no recommended dietary allowance exists for this nutrient. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[27]  M. L. Scott,et al.  Nutritional Interrelationships of Vitamin E and Selenium , 1977 .

[28]  T. Chen,et al.  Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  J. Hsia,et al.  Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized controlled trial , 2002 .

[30]  A. Chait,et al.  Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease☆ , 2002 .

[31]  G. Combs.  Considering the mechanisms of cancer prevention by selenium. , 2001, Advances in experimental medicine and biology.

[32]  L. Klotz,et al.  Selenium modulation of cell proliferation and cell cycle biomarkers in human prostate carcinoma cell lines. , 2002, Cancer research.

[33]  M. Campbell,et al.  Mechanisms of decreased Vitamin D 1α-hydroxylase activity in prostate cancer cells , 2004, Molecular and Cellular Endocrinology.

[34]  J. S. Morris,et al.  Association Between α-Tocopherol, γ-Tocopherol, Selenium, and Subsequent Prostate Cancer , 2000 .

[35]  A. Kristal,et al.  Centralized Blood Processing for the Selenium and Vitamin E Cancer Prevention Trial: Effects of Delayed Processing on Carotenoids, Tocopherols, Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein 3, Steroid Hormones, and Lymphocyte Viability , 2005, Cancer Epidemiology Biomarkers & Prevention.

[36]  D. Albanes,et al.  The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[37]  Scott M Lippman,et al.  Science peels the onion of selenium effects on prostate carcinogenesis. , 2004, Journal of the National Cancer Institute.

[38]  J. Hsia,et al.  Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized control trial , 2003 .

[39]  C. Abnet,et al.  Prospective Study of Serum Vitamin E Levels and Esophageal and Gastric Cancers , 2003 .

[40]  Deborah Gustafson,et al.  Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. , 2004, Archives of neurology.

[41]  J. Blumberg,et al.  Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. , 1997, JAMA.

[42]  D. Albanes,et al.  Long-term alpha-tocopherol supplementation is associated with lower serum vascular endothelial growth factor levels. , 2002, Anticancer Research.

[43]  A. Anagnostou,et al.  dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. , 1997, Nutrition and cancer.

[44]  G. Wilding,et al.  Androgen antagonist activity by the antioxidant moiety of vitamin E, 2,2,5,7,8-pentamethyl-6-chromanol in human prostate carcinoma cells. , 2003, Molecular cancer therapeutics.

[45]  W. Yu,et al.  Vitamin E Succinate Induces Apoptosis in Human Prostate Cancer Cells: Role for Fas in Vitamin E Succinate-Triggered Apoptosis , 2000, Nutrition and cancer.

[46]  P Woodbury,et al.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. , 1997, The New England journal of medicine.

[47]  J. Tyson,et al.  Element selective characterization of stability and reactivity of selenium species in selenized yeast , 2004 .

[48]  D. Albanes,et al.  Serum α-Tocopherol and γ-Tocopherol in Relation to Prostate Cancer Risk in a Prospective Study , 2005 .

[49]  H. Steinhart,et al.  Antioxidant Vitamin Supplementation in Crohn's Disease Decreases Oxidative Stress: A Randomized Controlled Trial , 2003, American Journal of Gastroenterology.

[50]  J. Crowley,et al.  19 Utility of the enrollment period in the Prostate Cancer Prevention Trial (PCPT) , 1997 .

[51]  A. Kristal,et al.  Vitamin Supplements and Cancer Risk , 2001 .

[52]  C. Ip,et al.  Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells. , 2003, Cancer research.

[53]  Alan C. Wilson,et al.  Correlates of Serum α- and γ-Tocopherol in the Women's Health Initiative , 2001 .

[54]  D. Albanes,et al.  Serum α-Tocopherol and Subsequent Risk of Lung Cancer Among Male Smokers , 1999 .

[55]  Mary E Reid,et al.  Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. , 2003, Journal of the National Cancer Institute.

[56]  H. Ganther,et al.  In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. , 2000, Cancer research.

[57]  Cheng Jiang,et al.  Dissociation of the genotoxic and growth inhibitory effects of selenium. , 1995, Biochemical pharmacology.

[58]  O. Levander,et al.  Naturally occurring selenium compounds in cancer chemoprevention trials: a workshop summary. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[59]  Bruce W. Turnbull,et al.  Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin: A Randomized Controlled Trial , 1996 .

[60]  E. Giovannucci.  Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: A hypothesis , 1998, Cancer Causes & Control.

[61]  G. Siegal,et al.  1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[62]  Roberto Pastor-Barriuso,et al.  Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality , 2005, Annals of Internal Medicine.

[63]  B. W. Nicholson,et al.  A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. , 1993, Archives of ophthalmology.

[64]  D. Bostwick,et al.  Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. , 2003, Journal of the National Cancer Institute.

[65]  S. Lippman,et al.  Can selenium prevent colorectal cancer? A signpost from epidemiology. , 2004, Journal of the National Cancer Institute.

[66]  D. Hamer,et al.  Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. , 2004, JAMA.

[67]  R A Stephenson,et al.  Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. , 2000, JAMA.

[68]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[69]  J. Crowley,et al.  Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT) , 2004, Cancer Causes & Control.

[70]  E. Messing,et al.  Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[71]  R. Deckelbaum,et al.  Primary and Secondary Preventive Nutrition , 2001, Nutrition and Health.

[72]  C. Steinmaus,et al.  Selenium and lung cancer: a quantitative analysis of heterogeneity in the current epidemiological literature. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[73]  D. Albanes,et al.  Effects of long‐term α‐tocopherol supplementation on serum hormones in older men * , 2001 .

[74]  C. Gluud,et al.  Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis , 2004, The Lancet.

[75]  G. Combs,et al.  The nutritional biochemistry of selenium. , 1984, Annual review of nutrition.

[76]  E. Larsen,et al.  Speciation and bioavailability of selenium in yeast-based intervention agents used in cancer chemoprevention studies. , 2004, Journal of AOAC International.

[77]  D. Albanes,et al.  Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. , 1999, Stroke.

[78]  S. Ripatti,et al.  Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. , 1998, Journal of the National Cancer Institute.

[79]  E. John,et al.  Residential sunlight exposure is associated with a decreased risk of prostate cancer , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[80]  C. Ip,et al.  Synergistic effect of vitamin E and selenium in the chemoprevention of mammary carcinogenesis in rats. , 1983, Cancer research.

[81]  A. Sabichi,et al.  Selenium effects on prostate cell growth. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[82]  D. Medina,et al.  Current ideas on selenium as a chemopreventive agent. , 1988, Pathology and immunopathology research.

[83]  A. Azzi,et al.  Vitamin E: protective role of a Janus molecule , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.